Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00746356 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of Automatic Testing Feature in New ICDs and CRT-Ds
A NA study of Heart Failure and Ventricular Arrythmias, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 128
- Enrollment target
- 5
- Study locations
NCT00746356: Completed NA study of Heart Failure and Ventricular Arrythmias, sponsored by Abbott Medical Devices.
NCT00746356 is a NA study of Heart Failure and Ventricular Arrythmias that has completed, run by Abbott Medical Devices. The registered enrollment target is 128 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (94% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00746356, a NA study of Heart Failure and Ventricular Arrythmias, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
- 5
- Study locations
Study Summary
This study is a prospective, non-randomized, multi-center clinical trial that will assess the safety and effectiveness of investigational models of the Promote™ RF CRT-D and Current™ RF ICD devices. These new ICD and CRT-D devices have new features that allow the device to periodically check how much energy is needed to pace a patient's heart and to automatically adjust the amount of energy used to pace the heart.
Conditions Studied
Interventions
- DEVICE Testing of the autocapture features of the device
Study Locations (5)
Arkansas
- Arkanasas Heart Hospital - Little Rock
- Baptist Health Hospital - Little Rock
New Jersey
- Deborah Heart and Lung Center - Browns Mills
Tennessee
- St. Thomas Hospital - Nashville
Texas
- Southwest Texas Methodist Hospital - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2008-08 |
| Est. Completion | 2010-01 |
| Phase | NA |
What the finished NCT00746356 record still lists
NCT00746356 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Testing of the autocapture features of the device is the first listed.
NCT00746356 lists 5 locations in 4 states (Arkansas, New Jersey, Tennessee).
Frequently Asked Questions
What is clinical trial NCT00746356 about?
NCT00746356 is a clinical study titled "Safety and Efficacy of Automatic Testing Feature in New ICDs and CRT-Ds". This study is a prospective, non-randomized, multi-center clinical trial that will assess the safety and effectiveness of investigational models of the Promote™ RF CRT-D and Current™ RF ICD devices. These new ICD and CRT-D devices have new features that allow the device to periodically check how muc...
What is the current status of trial NCT00746356?
This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2008-08. Estimated completion is 2010-01.
What conditions does trial NCT00746356 study?
This clinical trial studies the following conditions: Heart Failure, Ventricular Arrythmias.
What interventions are being tested in trial NCT00746356?
The interventions under investigation include: Testing of the autocapture features of the device (DEVICE).
Who is sponsoring clinical trial NCT00746356?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00746356 being conducted?
This trial has 5 study locations across Arkansas, New Jersey, Tennessee, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00746356's enrollment target sits among peer trials
128 199th of 397 higher than 198 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02870738 · 128 participants · Phase 2
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
- NCT03294460 · 128 participants · Phase 1
Nicotinic Receptor Genetic Variation and Alcohol Reward
- NCT04149977 · 128 participants · NA
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
- NCT04373057 · 128 participants · Phase 1
Prebiotic Galacto-oligosaccharide and Acute GVHD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia